@prefix : <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis> .

<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis> rdf:type owl:Ontology ;
                                                                                                                                  owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ;
                                                                                                                                  rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255521"^^xsd:anyURI ;
                                                                                                                                  rdfs:label "Propylthiouracil and Stevens-Johnson syndrome, Erythema multiforme and Epidermal necrolysis"^^xsd:Literal ;
                                                                                                                                  owl:versionInfo "draft-v0.95-20210614"@en .

#################################################################
#    Annotation properties
#################################################################

###  http://purl.org/dc/elements/1.1/publisher
dc:publisher rdf:type owl:AnnotationProperty .


###  http://purl.org/dc/terms/hasVersion
terms:hasVersion rdf:type owl:AnnotationProperty .


###  http://www.w3.org/2004/02/skos/core#exactMatch
skos:exactMatch rdf:type owl:AnnotationProperty .


###  http://www.w3.org/2004/02/skos/core#inScheme
skos:inScheme rdf:type owl:AnnotationProperty .


###  http://www.w3.org/2004/02/skos/core#notation
skos:notation rdf:type owl:AnnotationProperty .


#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Addendum
:Addendum rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Free_text_reporting_element ;
          OpenPVSignal:has_content "As of February 2013 there were 13 ICSRs for Stevens-Johnson syndrome, 14 ICSRs for erythema multiforme and 6 ICSRs for epidermal necrolysis." ;
          rdfs:label "Addendum" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#ConclusionContent
:ConclusionContent rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Conclusion ;
                   OpenPVSignal:has_content "There is a general lack of information in the case reports; however, there is sufficient information to suggest that this is a signal as it provides information on a possible causal relationship between propylthiouracil and Stevens-Johnson syndrome, erythema multiforme and epidermal necrolysis that was incompletely documented previously. Given the serious nature of the outcome, further evaluation is warranted." ;
                   rdfs:label "Conclusion content" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#DiscussionContent
:DiscussionContent rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Discussion ;
                   OpenPVSignal:has_content """SJS, EM and EN are all serious ADRs that may be caused by a wide range of drugs, but may also have infectious, malignancy-related or idiopathic causes. They can affect patients of all ages and races and, although SJS and EN are slightly more common in women, the large proportion of women affected in these cases can also be explained by hyperthyroidism being more prevalent in women. The indication for PTU, hyperthyroidism, is unlikely to explain the outcome of SJS, EM or EN however co-morbidities, such as infection, might.
The ICSRs identified have variable amounts of detail with limited information for assessment of causality. Where a causal link between drug and outcome was given, nine were thought to be 'possible' and nine 'probable'. PTU was the sole suspected drug in 23 of the reports (77%). Most reports (22 of 30) provided information to establish that drug exposure preceded development of the ADR. This supports the hypothesis that these adverse reactions may be linked to PTU, however incomplete information regarding duration of therapy, timing of event, and concomitant drug use and co-morbidities makes this uncertain. Information on positive dechallenge was given in six cases; however, there were no recorded re-challenges.""" ;
                   rdfs:label "Discussion content" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Dosage_for_reports_with_EN_and_PTU
:Dosage_for_reports_with_EN_and_PTU rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Dosage ;
                                    OpenPVSignal:refers_to_drug :propylthiouracil ;
                                    OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                                    OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                                    OpenPVSignal:has_value 150 ,
                                                           300 ;
                                    OpenPVSignal:refers_to_dose_value "150 mg" ,
                                                                      "300 mg" ;
                                    rdfs:label "Dosage for reports with EN and PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Dr_Zarif_Jabbar-Lopez
:Dr_Zarif_Jabbar-Lopez rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Author ;
                       OpenPVSignal:has_affiliation "Upssala Monitoring Center" ;
                       OpenPVSignal:has_first_name "Zarif" ;
                       OpenPVSignal:has_last_name "Jabbar-Lopez" ;
                       rdfs:label "Dr Zarif Jabbar-Lopez" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Drugdex
:Drugdex rdf:type owl:NamedIndividual ,
                  obo:OAE_0001197 ;
         OpenPVSignal:refers_to_adverse_effect :maculopapular_rash ;
         OpenPVSignal:refers_to_drug :e ,
                                     :propylthiouracil ;
         mp:references :Ref.11 ,
                       :Ref.4 ;
         OpenPVSignal:has_content "Drugdex mentions the occurrence of maculopapular rashes in 5-6% of patients using PTU and methimazole with variable onset.4,11" ;
         rdfs:label "Drugdex" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Hyperthyroidism
:Hyperthyroidism rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Free_text_reporting_element ;
                 OpenPVSignal:refers_to_adverse_effect :hyperthyroidism ;
                 mp:references :Ref.2 ;
                 OpenPVSignal:has_content "Hyperthyroidism is a common disorder characterised by thyroid gland overactivity resulting in excessive synthesis and secretion of thyroid hormones. The commonest cause of hyperthyroidism is the autoimmune condition Graves' disease. Excess thyroid hormone over- stimulates metabolism and exacerbates the effect of the sympathetic nervous system causing anxiety, increased perspiration, palpitations, tachycardia, tremors, digestive system hypermotility etc. Women are 2-10 times more likely to develop hyperthyroidism than men.2" ;
                 rdfs:label "hyperthyroidism pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Initial_dosage_1_for_severe_for_PTU
:Initial_dosage_1_for_severe_for_PTU rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Dosage ;
                                     OpenPVSignal:refers_to_drug :propylthiouracil ;
                                     OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                                     OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                                     OpenPVSignal:has_value 600 ;
                                     OpenPVSignal:refers_to_dose_value "600 mg" ;
                                     rdfs:label "Initial dosage 1 for severe for PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Initial_dosage_2_for_severe_for_PTU
:Initial_dosage_2_for_severe_for_PTU rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Dosage ;
                                     OpenPVSignal:refers_to_drug :propylthiouracil ;
                                     OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                                     OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                                     OpenPVSignal:has_value 1200 ;
                                     OpenPVSignal:refers_to_dose_value "1200 mg" ;
                                     rdfs:label "Initial dosage 2 for severe for PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#IntroductionContent
:IntroductionContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Introduction ;
                     mp:references :Ref.1 ,
                                   :Ref.2 ,
                                   :Ref.3 ,
                                   :Ref.4 ,
                                   :Ref.5 ,
                                   :Ref.6 ,
                                   :Ref.7 ,
                                   :Ref.8 ,
                                   :Ref.9 ;
                     OpenPVSignal:has_content """The drug-ADR combination of propylthiouracil and Stevens-Johnson syndrome was highlighted during testing of a new quantitative method for detecting potential signals at the UMC in 2012.1 A search of the WHO Global ICSR database, VigiBase™, showed additional reports of erythema multiforme and epidermal necrolysis which were also included in this assessment. Hyperthyroidism is a common disorder characterised by thyroid gland overactivity resulting in excessive synthesis and secretion of thyroid hormones. The commonest cause of hyperthyroidism is the autoimmune condition Graves' disease. Excess thyroid hormone over- stimulates metabolism and exacerbates the effect of the sympathetic nervous system causing anxiety, increased perspiration, palpitations, tachycardia, tremors, digestive system hypermotility etc. Women are 2-10 times more likely to develop hyperthyroidism than men.2
Propylthiouracil (PTU) is a thiouracil-derived drug used to treat hyperthyroidism, including Graves' disease. It is also used to alleviate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole (carbimazole) and in the treatment of thyroid storm. PTU acts by inhibiting the formation of thyroid hormones. It does not interfere with the existing triiodothyronine within the thyroid or circulating in the blood, nor does it affect thyroid hormone activity. PTU is usually given orally. Initial doses range from 200 to 400 mg daily, although in severe cases initial doses of 600 to 1200 mg daily have been used. Once the patient's thyroid gland function normalises the dose is gradually reduced to a maintenance dose of 50 to 150 mg daily.3,4
Stevens-Johnson syndrome (SJS) is an immune- complex-mediated hypersensitivity reaction that involves the skin and mucous membranes. It is characterized by mucous ulceration, conjunctivitis and epidermal necrosis. SJS is a rare, serious and potentially fatal disorder that is often, but not always, due to drugs. Drugs commonly implicated in SJS include antibiotics, non-steroidal anti- inflammatory drugs, allopurinol and anti- convulsants.5,6
Erythema multiforme (EM) is a similar reaction to SJS and has at times been described as synonymous. In the 1990's however, Bastuji and Roujeau suggested that EM should be restricted to patients with typical target lesions or raised edematous papules, with or without mucosal involvement, and that SJS should be used for a syndrome characterised by mucous membrane erosions and widespread small blisters that arise on erythematous or purpuric maculae that are different from classic targets.7
Epidermal necrolysis (EN) like SJS, is a severe epidermolytic disorder usually caused by drugs, although other causes such as infection can occur. EN and SJS are considered by many to be the same disease, differing only by their extent of skin detachment, where in the case of EN a larger proportion of the body surface area is affected.
SJS and EN can be life-threatening. The average reported mortality rate of SJS is 1-5%, and of EN is 25-35%. Elderly patients and those with a large
 surface area of epidermal detachment are at a higher risk.8,9""" ;
                     rdfs:label "Introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#LiteratureAndLabelling
:LiteratureAndLabelling rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Literature_information ;
                        mp:references :Ref.10 ,
                                      :Ref.11 ,
                                      :Ref.4 ;
                        OpenPVSignal:has_content """A literature search found one case where SJS and acute interstitial nephritis developed in a 90-year- old woman after 5 weeks of PTU therapy for hyperthyroidism. The patient presented on admission with a generalized macular purpuric eruption accompanied by oral and genital mucosal erosions; acute renal failure was also present. Despite PTU withdrawal and corticosteroid treatment, intense desquamation occurred and the patient died 15 days after hospital admission.
Histopathological studies of a skin biopsy were compatible with SJS.10
Apart from the above, no other cases were identified on searching the literature. The US Product Information (PI) lists erythema nodosum, exfoliative dermatitis, skin ulcers, skin pigmentation, urticaria and rash. Drugdex mentions the occurrence of maculopapular rashes in 5-6% of patients using PTU and methimazole with variable onset.4,11""" ;
                        rdfs:label "Literature and Labelling" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Maintenance_dosage_1_for_PTU
:Maintenance_dosage_1_for_PTU rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Dosage ;
                              OpenPVSignal:refers_to_drug :propylthiouracil ;
                              OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                              OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                              OpenPVSignal:has_value 50 ;
                              OpenPVSignal:refers_to_dose_value "50 mg" ;
                              rdfs:label "Maintenance dosage 1 for PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Maintenance_dosage_2_for_PTU
:Maintenance_dosage_2_for_PTU rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Dosage ;
                              OpenPVSignal:refers_to_drug :propylthiouracil ;
                              OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                              OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                              OpenPVSignal:has_value 150 ;
                              OpenPVSignal:refers_to_dose_value "150 mg" ;
                              rdfs:label "Maintenance dosage 2 for PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#MechanismOfPropylthiouracil
:MechanismOfPropylthiouracil rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Mechanism ;
                             mp:references :Ref.3 ,
                                           :Ref.4 ;
                             OpenPVSignal:has_content "Propylthiouracil (PTU) is a thiouracil-derived drug used to treat hyperthyroidism, including Graves' disease. It is also used to alleviate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole (carbimazole) and in the treatment of thyroid storm. PTU acts by inhibiting the formation of thyroid hormones. It does not interfere with the existing triiodothyronine within the thyroid or circulating in the blood, nor does it affect thyroid hormone activity." ;
                             rdfs:label "Mechanism of propylthiouracil" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#One_day_interval
:One_day_interval rdf:type owl:NamedIndividual ,
                           <http://www.w3.org/2006/time#DurationDescription> ;
                  <http://www.w3.org/2006/time#nominalPosition> "days" ;
                  <http://www.w3.org/2006/time#numericPosition> 1 ;
                  rdfs:label "One day interval" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Overall_reports_with_PTU
:Overall_reports_with_PTU rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:refers_to_drug :propylthiouracil ;
                          OpenPVSignal:has_count 30 ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "Overall reports with PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#PatientFromLiterature
:PatientFromLiterature rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Patient ;
                       OpenPVSignal:has_age 90 ;
                       OpenPVSignal:has_gender "female" ;
                       rdfs:label "Patient from Literature" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Caster O, Norén GN, Madigan D, Bate A. Large-scale regression-based pattern discovery: the example of screening the WHO global drug safety database. Statistical analysis and data mining 2010;3(4):197-208." ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.10
:Ref.10 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Dysseleer A, Buysschaert M, Fonck C, Van Ginder Deuren K, Jadoul M, Tennstedt D et al. Case history: Acute interstitial nephritis and fatal Stevens-Johnson syndrome after propylthiouracil therapy. Thyroid 2000;10(8):713-716." ;
        rdfs:label "Ref.10" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.11
:Ref.11 rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Bibliographic_reference ;
        OpenPVSignal:has_content "Drugdex on propylthiouracil. URL: http://www.thomsonhc.com. Accessed: 15 November 2012" ;
        rdfs:label "Ref.11" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Braverman L, Wartofsky L, Sarlis N, Babar N. Hyperthyriodism.URL: http://endocrine.niddk.nih.gov. Accessed: 15 November 2012." ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Martindale on propylthiouracil. URL: http://www.thomsonhc.com. Accessed: 15 November 2012." ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "US PI for propylthiouracil (Propylthiouracil). URL: http://www.accessdata.fda.gov/scripts/cder/drugs atfda.Accessed: 15 November 2012." ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Foster CS. Stevens-Johnson syndrome. URL: http://emedicine.medscape.com. Accessed: 16 November 2012." ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.6
:Ref.6 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content """Ngan V, Oakley A, Dyall-Smith D. Stevens Johnson syndrome & toxic epidermal necrolysis. URL: http://dermnetnz.org/reactions/sjs- ten.html.
Accessed: 16 November 2012.""" ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.7
:Ref.7 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol. 1997 Nov;24(11):726-9." ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.8
:Ref.8 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006 Mar;55(1):9-16." ;
       rdfs:label "Ref.8" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Ref.9
:Ref.9 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39." ;
       rdfs:label "Ref.9" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Report_from_Literature
:Report_from_Literature rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Individual_Case_Safety_Report ;
                        OpenPVSignal:concerns_indication_for_use :hyperthyroidism ;
                        OpenPVSignal:refers_to_adverse_effect :acuteInterstitialNephritis ,
                                                              :acuteRenalFailure ,
                                                              :mucosalErosion ,
                                                              :purpuricEruption ,
                                                              :stevens-johnsonSyndrome ;
                        OpenPVSignal:refers_to_patient :PatientFromLiterature ;
                        OpenPVSignal:refers_to_primary_suspect_drug :propylthiouracil ;
                        OpenPVSignal:time_to_onset :time_to_onset_for_literature_report ;
                        mp:references :Ref.10 ;
                        OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
                        OpenPVSignal:refers_to_outcome_after_action "death" ;
                        rdfs:label "Report from Literature" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#ReportsInVigibase
:ReportsInVigibase rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Free_text_reporting_element ;
                   OpenPVSignal:has_content """Stevens-Johnson Syndrome
Report factors
In October 2012 there were 12 ICSRs in VigiBase relating to PTU and SJS. The reports came from diverse geographical locations: four of the 12 reports were from North America, two from Europe, one from Australia and five from Asia.
Thailand had the single largest number of reports (four). The first reported case was in 1975 and the latest was from 2010.
Data on causality assessment, co-morbidities and concomitant medications was limited. Further data were available, in the form of the original reports from National Pharmacovigilance Centres (NCs), on ten of the reports.
Patient factors
All but one of the patients were female. Patient ages ranged from 32 to 73 years, with a median age of 48 years. Only two reports provided information on patient co-morbidities. One patient died, five patients recovered, one patient had not recovered at the time the report was made, and the status of the remaining five patients was either unknown or not recorded.
Drug factors
PTU was the only drug suspected of causing SJS in nine of the patients. The remaining three patients received other drugs in addition to PTU that were thought to be responsible for the adverse event, namely tetracycline, carbimazole or cefuroxime.
Doses of 100 mg to 400 mg daily of PTU were used; however, dosage was not recorded in 5 of the cases. Time to onset of SJS ranged from 6 to 35 days from initiation of therapy with PTU. Three cases did not provide sufficient information to determine time to onset of the outcome.


Erythema multiforme
Report factors
There were 14 ICSRs submitted where PTU was the suspected drug in relation to EM between 1985 and 2011. Four of the reports were from Europe, five from the US and five from Thailand. The majority of the reports had limited information, but further data was collected from seven original reports provided by NCs.
Patient factors
The majority of the reports related to female patients, with only two of the reports concerning men. Ages ranged from 21 to 73 years with a median age of 44.5 years. Only four reports had information on any medical history. One report regarding a 73-year-old woman from the US also had SJS reported. One patient died and the report states that the reaction might have been contributory. Three patients had recovered at the time of report writing (one with sequelae), seven had not, and for the remainder there was no information regarding outcome.
Drug factors
PTU was the only suspected drug in 10 of the reports. In the remaining 4 reports the patients had been taking other drugs that may have contributed to the reaction, namely ibuprofen, paracetamol or cefuroxime. Information on doses of PTU was very limited, but when given they ranged from 50 mg to 1000 mg. Time to onset of reaction ranged from 1 day to 28 months (although one report indicated 11 years and one might assume a coding error) in the nine cases this information was given.

Epidermal necrolysis
Report factors
Four ICSRs from Thailand and one from the UK were assessed in relation to PTU and epidermal necrolysis. In three of these cases original reports provided additional information. The adverse events occurred between 1993 and 2007.
Patient factors
All five patients were female and their ages ranged from 30 and 69 years, with a median age of 43. In one report co-morbidities were reported (apart from Graves' disease the patient also had Crohn's disease, egg and milk allergy, penicillin allergy and short bowel syndrome). One patient died (PTU was the sole suspected drug), two recovered (one with sequelae) and the other two had not recovered at the time of report writing.
Drug factors
PTU was the sole suspected drug in four of the reports and in one report propranolol was also suspected. Three reports had at least one concomitant drug known to cause EN, but there was limited information on duration of use. In two cases the drug was withdrawn and the reaction abated. The dose was recorded in four reports and ranged from 150 to 300 mg daily. All five cases had information on time to onset, which ranged from 1 day to 35 days.""" ;
                   rdfs:label "Reports in vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#SummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content "In October 2012 the WHO Global Individual Case Safety Report (ICSR) database, Vigibase™, had a total of 30 ICSRs concerning Stevens-Johnson syndrome, erythema multiforme or epidermal necrolysis in relation to propylthiouracil as the suspected drug. Propylthiouracil is an antithyroid drug indicated for treatment of hyperthyroidism, including Graves' disease, in patients intolerant of methimazole. According to labelling information, propylthiouracil has an established association with dermatological events such as erythema nodosum, exfoliative dermatitis and rash. A previously documented literature case regarding Stevens-Johnson syndrome together with the findings of this assessment indicates that there is cause for further investigation." ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#USPI
:USPI rdf:type owl:NamedIndividual ,
               obo:OAE_0001197 ,
               OpenPVSignal:Structured_Product_Labels_information ,
               OpenPVSignal:Warning_Information ;
      OpenPVSignal:refers_to_adverse_effect :erythemaNodosum ,
                                            :exfoliativeDermatitis ,
                                            :rash ,
                                            :skinPigmentation ,
                                            :urticaria ;
      OpenPVSignal:refers_to_drug :propylthiouracil ;
      mp:references :Ref.4 ;
      OpenPVSignal:has_content "The US Product Information (PI) lists erythema nodosum, exfoliative dermatitis, skin ulcers, skin pigmentation, urticaria and rash." ;
      rdfs:label "USPI" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Uppsala_monitoring_centre
:Uppsala_monitoring_centre rdf:type owl:NamedIndividual ,
                                    prov:Organization ;
                           rdfs:label "Uppsala monitoring centre" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Usage_for_reports_with_EN_and_PTU
:Usage_for_reports_with_EN_and_PTU rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Drug_Usage ;
                                   OpenPVSignal:refers_to_dosage :Dosage_for_reports_with_EN_and_PTU ;
                                   rdfs:label "Usage for reports with EN and PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Usual_dosage_1_for_PTU
:Usual_dosage_1_for_PTU rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Dosage ;
                        OpenPVSignal:refers_to_drug :propylthiouracil ;
                        OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                        OpenPVSignal:has_value 200 ;
                        OpenPVSignal:refers_to_dose_value "200 mg" ;
                        rdfs:label "Usual dosage 1 for PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Usual_dosage_2_for_PTU
:Usual_dosage_2_for_PTU rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Dosage ;
                        OpenPVSignal:refers_to_drug :propylthiouracil ;
                        OpenPVSignal:refers_to_interval_between_administrations :One_day_interval ;
                        OpenPVSignal:has_dosage_unit "mg"^^xsd:string ;
                        OpenPVSignal:has_value 400 ;
                        OpenPVSignal:refers_to_dose_value "400 mg" ;
                        rdfs:label "Usual dosage 2 for PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#acuteInterstitialNephritis
:acuteInterstitialNephritis rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Adverse_Effect ;
                            OpenPVSignal:has_MedDRA_code 10000819 ;
                            OpenPVSignal:has_MedDRA_prefered_term "Acute interstitial nephritis" ;
                            rdfs:label "acute interstitial nephritis" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#acuteRenalFailure
:acuteRenalFailure rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "N179" ;
                   OpenPVSignal:has_MedDRA_code 10069339 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Acute kidney injury" ;
                   rdfs:label "acute renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#carbimazole
:carbimazole rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ,
                      OpenPVSignal:Potential_Confounder ;
             OpenPVSignal:has_ATC_code "H03BB01" ;
             rdfs:label "carbimazole" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#cefuroxime
:cefuroxime rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ,
                     OpenPVSignal:Potential_Confounder ;
            OpenPVSignal:has_ATC_code "J01DC02" ,
                                      "J01RA03" ,
                                      "S01AA27" ;
            rdfs:label "cefuroxime" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#e
:e rdf:type owl:NamedIndividual ,
            OpenPVSignal:Drug ;
   OpenPVSignal:has_ATC_code "H03BB02" ;
   rdfs:label "methimazole" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#epidermalNecrolysis
:epidermalNecrolysis rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "L51.2" ;
                     OpenPVSignal:has_MedDRA_code 10044223 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Toxic epidermal necrolysis" ;
                     rdfs:label "epidermal necrolysis" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#epidermal_necrolysis_pathophysiology
:epidermal_necrolysis_pathophysiology rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Free_text_reporting_element ;
                                      OpenPVSignal:refers_to_adverse_effect :epidermalNecrolysis ;
                                      mp:references :Ref.8 ,
                                                    :Ref.9 ;
                                      OpenPVSignal:has_content "Epidermal necrolysis (EN) like SJS, is a severe epidermolytic disorder usually caused by drugs, although other causes such as infection can occur. EN and SJS are considered by many to be the same disease, differing only by their extent of skin detachment, where in the case of EN a larger proportion of the body surface area is affected. SJS and EN can be life-threatening. The average reported mortality rate of SJS is 1-5%, and of EN is 25-35%. Elderly patients and those with a large surface area of epidermal detachment are at a higher risk.8,9" ;
                                      rdfs:label "epidermal necrolysis pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#erythemaMultiforme
:erythemaMultiforme rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "L519" ;
                    OpenPVSignal:has_MedDRA_code 10015218 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Erythema multiforme" ;
                    rdfs:label "erythema multiforme" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#erythemaNodosum
:erythemaNodosum rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "L52" ;
                 OpenPVSignal:has_MedDRA_code 10015226 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Erythema nodosum" ;
                 rdfs:label "erythema nodosum" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#erythema_multiforme_pathophysiology
:erythema_multiforme_pathophysiology rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Free_text_reporting_element ;
                                     OpenPVSignal:refers_to_adverse_effect :erythemaMultiforme ;
                                     mp:references :Ref.7 ;
                                     OpenPVSignal:has_content "Erythema multiforme (EM) is a similar reaction to SJS and has at times been described as synonymous. In the 1990's however, Bastuji and Roujeau suggested that EM should be restricted to patients with typical target lesions or raised edematous papules, with or without mucosal involvement, and that SJS should be used for a syndrome characterised by mucous membrane erosions and widespread small blisters that arise on erythematous or purpuric maculae that are different from classic targets.7" ;
                                     rdfs:label "erythema multiforme pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#exfoliativeDermatitis
:exfoliativeDermatitis rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "L26" ;
                       OpenPVSignal:has_MedDRA_code 10012455 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Dermatitis exfoliative" ;
                       rdfs:label "exfoliative dermatitis" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#hyperthyroidism
:hyperthyroidism rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ,
                          OpenPVSignal:Indication ;
                 OpenPVSignal:has_ICD_code "E05.90" ;
                 OpenPVSignal:has_MedDRA_code 10020850 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Hyperthyroidism" ;
                 rdfs:label "hyperthyroidism" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#ibuprofen
:ibuprofen rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ,
                    OpenPVSignal:Potential_Confounder ;
           OpenPVSignal:has_ATC_code "C01EB16" ,
                                     "G02CC01" ,
                                     "M01AE01" ,
                                     "M01AE51" ,
                                     "M02AA13" ,
                                     "R02AX02" ;
           rdfs:label "ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#maculopapular_rash
:maculopapular_rash rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_MedDRA_code 10025424 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Maculopapular rash" ;
                    rdfs:label "maculopapular rash" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#mucosalErosion
:mucosalErosion rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_MedDRA_code 10061297 ;
                OpenPVSignal:has_MedDRA_prefered_term "Mucosal erosion" ;
                rdfs:label "mucosal erosion" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#oral_administration
:oral_administration rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Intake_Form ;
                     OpenPVSignal:refers_to_form_of_intake "oral" ;
                     rdfs:label "oral administration" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#paracetamol
:paracetamol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ,
                      OpenPVSignal:Potential_Confounder ;
             OpenPVSignal:has_ATC_code "N02BE01" ;
             rdfs:label "paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#propranolol
:propranolol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C07AA05" ,
                                       "C07BA05" ,
                                       "C07FA05" ;
             rdfs:label "propranolol" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#propylthiouracil
:propylthiouracil rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Drug ;
                  OpenPVSignal:has_mechanism :MechanismOfPropylthiouracil ;
                  OpenPVSignal:has_ATC_code "H03BA02" ;
                  rdfs:label "propylthiouracil" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#purpuricEruption
:purpuricEruption rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "L81.7" ;
                  OpenPVSignal:has_MedDRA_prefered_term "Pigmented purpuric dermatosis" ;
                  rdfs:label "purpuric eruption" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :Addendum ,
                                                   :ConclusionContent ,
                                                   :Hyperthyroidism ,
                                                   :IntroductionContent ,
                                                   :ReportsInVigibase ,
                                                   :SummaryContent ,
                                                   :epidermal_necrolysis_pathophysiology ,
                                                   :erythema_multiforme_pathophysiology ,
                                                   :stevenJohnson ;
          OpenPVSignal:is_supported_by_individual_case_report :Report_from_Literature ;
          OpenPVSignal:is_supported_by_statistical_entity :Overall_reports_with_PTU ,
                                                          :reportsAsOfFebruary2013-PTUAndEM ,
                                                          :reportsAsOfFebruary2013-PTUAndEN ,
                                                          :reportsAsOfFebruary2013-PTUAndSJS ,
                                                          :reportsOfPtuBeingTheSoleSuspectDrug ,
                                                          :reportsWithPositiveDechallenge ,
                                                          :reports_with_possible_causal_link ,
                                                          :reports_with_probable_causal_link ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromEurope> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromThailand> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromUS> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithNoRecoveryAsOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithPtuBeingTheOnlySuspectedDrug> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithRecoveryAsOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReprotsWithFatalOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)_reports_with_SJS> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)_reports_with_recovery_with_sequelae_as_outcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithConfoundingmedication/co-suspect> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsFromThailand> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsFromUk> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithNoRecoveryAsOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPTUBeingTheSoleSuspectDrug> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPositiveDechallenge> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPropranololBeingTheSuspectDrug> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithRecoveryAsOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_usage_info> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_with_PTU_being_the_only_suspect_drug> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_with_recovery_with_sequelae_as_outcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromAsia> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromAustralia> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromEurope> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromNorthAmerica> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromThailand> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithFatalOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithPTUBeingTheOnlySuspectDrug> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithRecveryAsOutcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)_reports_with_no_recovery_as_outcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)_reports_with_unknown_outcome> ,
                                                          <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithConfoundingmedication/co-suspect> ;
          mp:supportedByData :Drugdex ,
                             :USPI ;
          OpenPVSignal:initially_identified_on "01/04/2020" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#rash
:rash rdf:type owl:NamedIndividual ,
               OpenPVSignal:Adverse_Effect ;
      OpenPVSignal:has_ICD_code "R21" ;
      OpenPVSignal:has_MedDRA_code 10037844 ;
      OpenPVSignal:has_MedDRA_prefered_term "Rash" ;
      rdfs:label "rash" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reportsAsOfFebruary2013-PTUAndEM
:reportsAsOfFebruary2013-PTUAndEM rdf:type owl:NamedIndividual ,
                                           OpenPVSignal:Reports_group ;
                                  OpenPVSignal:refers_to_drug :propylthiouracil ;
                                  OpenPVSignal:refers_to_unconfirmed_adverse_effect :erythemaMultiforme ;
                                  OpenPVSignal:has_count 14 ;
                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                  rdfs:label "reports as of February 2013-PTU and EM" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reportsAsOfFebruary2013-PTUAndEN
:reportsAsOfFebruary2013-PTUAndEN rdf:type owl:NamedIndividual ,
                                           OpenPVSignal:Reports_group ;
                                  OpenPVSignal:refers_to_drug :propylthiouracil ;
                                  OpenPVSignal:refers_to_unconfirmed_adverse_effect :epidermalNecrolysis ;
                                  OpenPVSignal:has_count 6 ;
                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                  rdfs:label "reports as of February 2013-PTU and EN" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reportsAsOfFebruary2013-PTUAndSJS
:reportsAsOfFebruary2013-PTUAndSJS rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:refers_to_drug :propylthiouracil ;
                                   OpenPVSignal:refers_to_unconfirmed_adverse_effect :stevens-johnsonSyndrome ;
                                   OpenPVSignal:has_count 13 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   rdfs:label "reports as of February 2013-PTU and SJS" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reportsOfPtuBeingTheSoleSuspectDrug
:reportsOfPtuBeingTheSoleSuspectDrug rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                     OpenPVSignal:refers_to_primary_suspect_drug :propylthiouracil ;
                                     OpenPVSignal:has_count 23 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports of ptu being the sole suspect drug" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reportsWithPositiveDechallenge
:reportsWithPositiveDechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                OpenPVSignal:has_count 6 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                rdfs:label "reports with positive dechallenge " .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reports_with_possible_causal_link
:reports_with_possible_causal_link rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                   OpenPVSignal:refers_to_drug :propylthiouracil ;
                                   OpenPVSignal:has_count 9 ;
                                   OpenPVSignal:has_evaluation "Possible" ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   rdfs:label "reports with possible causal link" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#reports_with_probable_causal_link
:reports_with_probable_causal_link rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                   OpenPVSignal:refers_to_drug :propylthiouracil ;
                                   OpenPVSignal:has_count 9 ;
                                   OpenPVSignal:has_evaluation "Probable" ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   rdfs:label "reports with probable causal link" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#skinPigmentation
:skinPigmentation rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "L81.9" ;
                  OpenPVSignal:has_MedDRA_code 10062080 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Pigmentation disorder" ;
                  rdfs:label "skin pigmentation" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#stevenJohnson
:stevenJohnson rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Free_text_reporting_element ;
               OpenPVSignal:refers_to_adverse_effect :stevens-johnsonSyndrome ;
               mp:references :Ref.5 ,
                             :Ref.6 ;
               OpenPVSignal:has_content "Stevens-Johnson syndrome (SJS) is an immune- complex-mediated hypersensitivity reaction that involves the skin and mucous membranes. It is characterized by mucous ulceration, conjunctivitis and epidermal necrosis. SJS is a rare, serious and potentially fatal disorder that is often, but not always, due to drugs. Drugs commonly implicated in SJS include antibiotics, non-steroidal anti- inflammatory drugs, allopurinol and anti- convulsants.5,6" ;
               rdfs:label "steven johnson pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#stevens-johnsonSyndrome
:stevens-johnsonSyndrome rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "L511" ;
                         OpenPVSignal:has_MedDRA_code 10042033 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Stevens-Johnson syndrome" ;
                         rdfs:label "stevens-johnson syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#tetracycline
:tetracycline rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ,
                       OpenPVSignal:Potential_Confounder ;
              OpenPVSignal:has_ATC_code "A01AB13" ,
                                        "A02BD02" ,
                                        "A02BD08" ,
                                        "D06AA04" ,
                                        "J01AA07" ,
                                        "J01AA20" ,
                                        "J01RA08" ,
                                        "S01AA09" ,
                                        "S02AA08" ,
                                        "S03AA02" ;
              rdfs:label "tetracycline" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#thyroidStorm
:thyroidStorm rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Indication ;
              OpenPVSignal:has_ICD_code "E05.21" ;
              OpenPVSignal:has_MedDRA_code 10043786 ;
              OpenPVSignal:has_MedDRA_prefered_term "Thyrotoxic crisis" ;
              rdfs:label "thyroid storm" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#time_to_onset_for_literature_report
:time_to_onset_for_literature_report rdf:type owl:NamedIndividual ,
                                              <http://www.w3.org/2006/time#DurationDescription> ;
                                     <http://www.w3.org/2006/time#nominalPosition> "weeks" ;
                                     <http://www.w3.org/2006/time#numericPosition> 5 ;
                                     rdfs:label "time to onset for literature report" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#urticaria
:urticaria rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "L509" ;
           OpenPVSignal:has_MedDRA_code 10046735 ;
           OpenPVSignal:has_MedDRA_prefered_term "Urticaria" ;
           rdfs:label "urticaria" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#usage_of_propylthiouracil
:usage_of_propylthiouracil rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Drug_Usage ;
                           OpenPVSignal:concerns_indication_for_use :hyperthyroidism ,
                                                                    :thyroidStorm ,
                                                                    <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#graves'Disease> ;
                           OpenPVSignal:is_related_with_drug_intake :oral_administration ;
                           OpenPVSignal:refers_to_dosage :Initial_dosage_1_for_severe_for_PTU ,
                                                         :Initial_dosage_2_for_severe_for_PTU ,
                                                         :Maintenance_dosage_1_for_PTU ,
                                                         :Maintenance_dosage_2_for_PTU ,
                                                         :Usual_dosage_1_for_PTU ,
                                                         :Usual_dosage_2_for_PTU ;
                           OpenPVSignal:refers_to_drug :propylthiouracil ;
                           rdfs:label "usage of propylthiouracil" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromEurope
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromEurope> rdf:type owl:NamedIndividual ,
                                                                                                                                                                    OpenPVSignal:Reports_group ;
                                                                                                                                                           OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                           OpenPVSignal:has_count 4 ;
                                                                                                                                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                           OpenPVSignal:refers_to_geographical_region "http://dbpedia.org/resource/Europe" ;
                                                                                                                                                           rdfs:label "(EM PTU)ReportsFromEurope" ,
                                                                                                                                                                      "(EM_PTU) Reports from Europe" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromThailand
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromThailand> rdf:type owl:NamedIndividual ,
                                                                                                                                                                      OpenPVSignal:Reports_group ;
                                                                                                                                                             OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                             OpenPVSignal:has_count 5 ;
                                                                                                                                                             OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Thailand" ;
                                                                                                                                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                             rdfs:label "(EM PTU)ReportsFromThailand" ,
                                                                                                                                                                        "(EM_PTU) Reports from Thailand" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromUS
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsFromUS> rdf:type owl:NamedIndividual ,
                                                                                                                                                                OpenPVSignal:Reports_group ;
                                                                                                                                                       OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                       OpenPVSignal:has_count 5 ;
                                                                                                                                                       OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_States" ;
                                                                                                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                       rdfs:label "(EM PTU)ReportsFromUS" ,
                                                                                                                                                                  "(EM_PTU) Reports from US" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> rdf:type owl:NamedIndividual ,
                                                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                                                      OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                                                                                                                                                      OpenPVSignal:refers_to_drug :propylthiouracil ;
                                                                                                                                                                      OpenPVSignal:refers_to_unconfirmed_adverse_effect :erythemaMultiforme ;
                                                                                                                                                                      OpenPVSignal:has_count 14 ;
                                                                                                                                                                      OpenPVSignal:has_count_of_men 2 ;
                                                                                                                                                                      OpenPVSignal:has_count_of_women 12 ;
                                                                                                                                                                      OpenPVSignal:has_max_age 73 ;
                                                                                                                                                                      OpenPVSignal:has_median_age "44.5"^^xsd:float ;
                                                                                                                                                                      OpenPVSignal:has_min_age "21.0"^^xsd:float ;
                                                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                      rdfs:label "(EM PTU)ReportsInVigibaseForEMAndPTU" ,
                                                                                                                                                                                 "(EM_PTU) reports in vigibase for EM and PTU" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithNoRecoveryAsOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithNoRecoveryAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                 OpenPVSignal:Reports_group ;
                                                                                                                                                                        OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                                        OpenPVSignal:has_count 7 ;
                                                                                                                                                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                        OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                                                                                                                                                        rdfs:label "(EM PTU)ReportsWithNoRecoveryAsOutcome" ,
                                                                                                                                                                                   "(EM_PTU) reports with no recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithPtuBeingTheOnlySuspectedDrug
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithPtuBeingTheOnlySuspectedDrug> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                          OpenPVSignal:Reports_group ;
                                                                                                                                                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                                                 OpenPVSignal:refers_to_primary_suspect_drug :propylthiouracil ;
                                                                                                                                                                                 OpenPVSignal:has_count 10 ;
                                                                                                                                                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                 rdfs:label "(EM PTU)ReportsWithPtuBeingTheOnlySuspectedDrug" ,
                                                                                                                                                                                            "(EM_PTU) reports with ptu being the only suspected drug" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithRecoveryAsOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithRecoveryAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                                      OpenPVSignal:has_count 2 ;
                                                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                      OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                                                                                                                                                                      rdfs:label "(EM PTU)ReportsWithRecoveryAsOutcome" ,
                                                                                                                                                                                 "(EM_PTU) reports with recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReprotsWithFatalOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReprotsWithFatalOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                          OpenPVSignal:Reports_group ;
                                                                                                                                                                 OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                                 OpenPVSignal:has_count 1 ;
                                                                                                                                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                 OpenPVSignal:refers_to_outcome_after_action "death" ;
                                                                                                                                                                 rdfs:label "(EM PTU)ReprotsWithFatalOutcome" ,
                                                                                                                                                                            "(EM_PTU) Reprots with fatal outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)_reports_with_SJS
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)_reports_with_SJS> rdf:type owl:NamedIndividual ,
                                                                                                                                                                    OpenPVSignal:Reports_group ;
                                                                                                                                                           OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                           OpenPVSignal:refers_to_adverse_effect :stevens-johnsonSyndrome ;
                                                                                                                                                           OpenPVSignal:has_count 1 ;
                                                                                                                                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                           rdfs:label "(EM PTU) reports with SJS" ,
                                                                                                                                                                      "(EM_PTU) reports with SJS" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)_reports_with_recovery_with_sequelae_as_outcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)_reports_with_recovery_with_sequelae_as_outcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                                  OpenPVSignal:Reports_group ;
                                                                                                                                                                                         OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                                                         OpenPVSignal:has_count 1 ;
                                                                                                                                                                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                         OpenPVSignal:refers_to_outcome_after_action "recovery with sequelae" ;
                                                                                                                                                                                         rdfs:label "(EM PTU) reports with recovery with sequelae as outcome" ,
                                                                                                                                                                                                    "(EM_PTU) reports with recovery with sequelae as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithConfoundingmedication/co-suspect
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsWithConfoundingmedication/co-suspect> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                              OpenPVSignal:Reports_group ;
                                                                                                                                                                                     OpenPVSignal:has_potential_confounding_factor :cefuroxime ,
                                                                                                                                                                                                                                   :ibuprofen ,
                                                                                                                                                                                                                                   :paracetamol ;
                                                                                                                                                                                     OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EM_PTU)ReportsInVigibaseForEMAndPTU> ;
                                                                                                                                                                                     OpenPVSignal:has_count 4 ;
                                                                                                                                                                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                     rdfs:label "(EM PTU)ReportsWithConfoundingmedication/co-suspect" ,
                                                                                                                                                                                                "(EM_PTU) reports with confounding medication/co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsFromThailand
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsFromThailand> rdf:type owl:NamedIndividual ,
                                                                                                                                                                      OpenPVSignal:Reports_group ;
                                                                                                                                                             OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                             OpenPVSignal:has_count 4 ;
                                                                                                                                                             OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Thailand" ;
                                                                                                                                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                             rdfs:label "(EN ptu)ReportsFromThailand" ,
                                                                                                                                                                        "(EN_ptu) reports from thailand" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsFromUk
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsFromUk> rdf:type owl:NamedIndividual ,
                                                                                                                                                                OpenPVSignal:Reports_group ;
                                                                                                                                                       OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                       OpenPVSignal:has_count 1 ;
                                                                                                                                                       OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_Kingdom" ;
                                                                                                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                       rdfs:label "(EN ptu)ReportsFromUk" ,
                                                                                                                                                                  "(EN_ptu) reports from uk" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithNoRecoveryAsOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithNoRecoveryAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                 OpenPVSignal:Reports_group ;
                                                                                                                                                                        OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                        OpenPVSignal:has_count 2 ;
                                                                                                                                                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                        OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                                                                                                                                                        rdfs:label "(EN ptu)ReportsWithNoRecoveryAsOutcome" ,
                                                                                                                                                                                   "(EN_ptu) reports with no recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPTUBeingTheSoleSuspectDrug
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPTUBeingTheSoleSuspectDrug> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                        OpenPVSignal:Reports_group ;
                                                                                                                                                                               OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                               OpenPVSignal:refers_to_primary_suspect_drug :propylthiouracil ;
                                                                                                                                                                               OpenPVSignal:has_count 1 ;
                                                                                                                                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                               OpenPVSignal:refers_to_outcome_after_action "death" ;
                                                                                                                                                                               rdfs:label "(EN ptu)ReportsWithPTUBeingTheSoleSuspectDrug" ,
                                                                                                                                                                                          "(EN_ptu) reports with death as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPositiveDechallenge
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPositiveDechallenge> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                 OpenPVSignal:Reports_group ;
                                                                                                                                                                        OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                        OpenPVSignal:has_count 2 ;
                                                                                                                                                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                        OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                                                                                                                                                        rdfs:label "(EN ptu)ReportsWithPositiveDechallenge" ,
                                                                                                                                                                                   "(EN_ptu) reports with positive dechallenge " .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPropranololBeingTheSuspectDrug
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithPropranololBeingTheSuspectDrug> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                            OpenPVSignal:Reports_group ;
                                                                                                                                                                                   OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                                   OpenPVSignal:refers_to_secondary_suspect_drug :propranolol ;
                                                                                                                                                                                   OpenPVSignal:has_count 1 ;
                                                                                                                                                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                   rdfs:label "(EN ptu)ReportsWithPropranololBeingTheSuspectDrug" ,
                                                                                                                                                                                              "(EN_ptu) reports with propranolol being co-suspect drug" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithRecoveryAsOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)ReportsWithRecoveryAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                      OpenPVSignal:has_count 1 ;
                                                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                      OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                                                                                                                                                                      rdfs:label "(EN ptu)ReportsWithRecoveryAsOutcome" ,
                                                                                                                                                                                 "(EN_ptu) reports with recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> rdf:type owl:NamedIndividual ,
                                                                                                                                                                   OpenPVSignal:Reports_group ;
                                                                                                                                                          OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                                                                                                                                          OpenPVSignal:refers_to_drug :propylthiouracil ;
                                                                                                                                                          OpenPVSignal:refers_to_unconfirmed_adverse_effect :epidermalNecrolysis ;
                                                                                                                                                          OpenPVSignal:has_count 5 ;
                                                                                                                                                          OpenPVSignal:has_count_of_women 5 ;
                                                                                                                                                          OpenPVSignal:has_max_age 69 ;
                                                                                                                                                          OpenPVSignal:has_median_age 43 ;
                                                                                                                                                          OpenPVSignal:has_min_age 30 ;
                                                                                                                                                          rdfs:label "(EN ptu) overall reports" ,
                                                                                                                                                                     "(EN_ptu) overall reports" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_usage_info
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_usage_info> rdf:type owl:NamedIndividual ,
                                                                                                                                                                      OpenPVSignal:Reports_group ;
                                                                                                                                                             OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                             OpenPVSignal:refers_to_reported_drug_usage :Usage_for_reports_with_EN_and_PTU ;
                                                                                                                                                             OpenPVSignal:has_count 4 ;
                                                                                                                                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                             rdfs:label "(EN ptu) reports usage info" ,
                                                                                                                                                                        "(EN_ptu) reports usage info" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_with_PTU_being_the_only_suspect_drug
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_with_PTU_being_the_only_suspect_drug> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                                OpenPVSignal:Reports_group ;
                                                                                                                                                                                       OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                                       OpenPVSignal:refers_to_primary_suspect_drug :propylthiouracil ;
                                                                                                                                                                                       OpenPVSignal:has_count 4 ;
                                                                                                                                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                       rdfs:label "(EN ptu) reports with PTU being the only suspect drug" ,
                                                                                                                                                                                                  "(EN_ptu) reports with PTU being the only suspect drug" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_with_recovery_with_sequelae_as_outcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_reports_with_recovery_with_sequelae_as_outcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                                  OpenPVSignal:Reports_group ;
                                                                                                                                                                                         OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(EN_ptu)_overall_reports> ;
                                                                                                                                                                                         OpenPVSignal:has_count 1 ;
                                                                                                                                                                                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                         OpenPVSignal:refers_to_outcome_after_action "recovery with sequelae" ;
                                                                                                                                                                                         rdfs:label "(EN ptu) reports with recovery with sequelae as outcome" ,
                                                                                                                                                                                                    "(EN_ptu) reports with recovery with sequelae as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> rdf:type owl:NamedIndividual ,
                                                                                                                                                                   OpenPVSignal:Reports_group ;
                                                                                                                                                          OpenPVSignal:is_subgroup_of :Overall_reports_with_PTU ;
                                                                                                                                                          OpenPVSignal:refers_to_drug :propylthiouracil ;
                                                                                                                                                          OpenPVSignal:refers_to_unconfirmed_adverse_effect :stevens-johnsonSyndrome ;
                                                                                                                                                          OpenPVSignal:has_count 12 ;
                                                                                                                                                          OpenPVSignal:has_count_of_men 1 ;
                                                                                                                                                          OpenPVSignal:has_count_of_women 11 ;
                                                                                                                                                          OpenPVSignal:has_max_age 73 ;
                                                                                                                                                          OpenPVSignal:has_median_age 48 ;
                                                                                                                                                          OpenPVSignal:has_min_age 32 ;
                                                                                                                                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                          rdfs:label "(PTU SJS)ReportsAnalyzed" ,
                                                                                                                                                                     "(PTU_SJS) overall reports" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromAsia
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromAsia> rdf:type owl:NamedIndividual ,
                                                                                                                                                                   OpenPVSignal:Reports_group ;
                                                                                                                                                          OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                          OpenPVSignal:has_count 5 ;
                                                                                                                                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                          OpenPVSignal:refers_to_geographical_region "http://dbpedia.org/resource/Asia" ;
                                                                                                                                                          rdfs:label "(PTU SJS)ReportsFromAsia" ,
                                                                                                                                                                     "(PTU_SJS) reports from asia" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromAustralia
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromAustralia> rdf:type owl:NamedIndividual ,
                                                                                                                                                                        OpenPVSignal:Reports_group ;
                                                                                                                                                               OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                               OpenPVSignal:has_count 1 ;
                                                                                                                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                               OpenPVSignal:refers_to_geographical_region "http://dbpedia.org/resource/Australia_(continent)" ;
                                                                                                                                                               rdfs:label "(PTU SJS)ReportsFromAustralia" ,
                                                                                                                                                                          "(PTU_SJS) reports from australia" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromEurope
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromEurope> rdf:type owl:NamedIndividual ,
                                                                                                                                                                     OpenPVSignal:Reports_group ;
                                                                                                                                                            OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                            OpenPVSignal:has_count 2 ;
                                                                                                                                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                            OpenPVSignal:refers_to_geographical_region "http://dbpedia.org/resource/Europe" ;
                                                                                                                                                            rdfs:label "(PTU SJS)ReportsFromEurope" ,
                                                                                                                                                                       "(PTU_SJS) reports from Europe" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromNorthAmerica
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromNorthAmerica> rdf:type owl:NamedIndividual ,
                                                                                                                                                                           OpenPVSignal:Reports_group ;
                                                                                                                                                                  OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                  OpenPVSignal:has_count 4 ;
                                                                                                                                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                  OpenPVSignal:refers_to_geographical_region "http://dbpedia.org/resource/North_America" ;
                                                                                                                                                                  rdfs:label "(PTU SJS)ReportsFromNorthAmerica" ,
                                                                                                                                                                             "(PTU_SJS) reports from North America" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromThailand
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsFromThailand> rdf:type owl:NamedIndividual ,
                                                                                                                                                                       OpenPVSignal:Reports_group ;
                                                                                                                                                              OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                              OpenPVSignal:has_count 4 ;
                                                                                                                                                              OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Thailand" ;
                                                                                                                                                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                              rdfs:label "(PTU SJS)ReportsFromThailand" ,
                                                                                                                                                                         "(PTU_SJS) reports from thailand" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithFatalOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithFatalOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                           OpenPVSignal:Reports_group ;
                                                                                                                                                                  OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                  OpenPVSignal:has_count 1 ;
                                                                                                                                                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                  OpenPVSignal:refers_to_outcome_after_action "death" ;
                                                                                                                                                                  rdfs:label "(PTU SJS)ReportsWithFatalOutcome" ,
                                                                                                                                                                             "(PTU_SJS) reports with fatal outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithPTUBeingTheOnlySuspectDrug
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithPTUBeingTheOnlySuspectDrug> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                         OpenPVSignal:Reports_group ;
                                                                                                                                                                                OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                                OpenPVSignal:refers_to_primary_suspect_drug :propylthiouracil ;
                                                                                                                                                                                OpenPVSignal:has_count 9 ;
                                                                                                                                                                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                rdfs:label "(PTU SJS)ReportsWithPTUBeingTheOnlySuspectDrug" ,
                                                                                                                                                                                           "(PTU_SJS) reports with PTU being the only suspect drug" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithRecveryAsOutcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithRecveryAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                      OpenPVSignal:has_count 5 ;
                                                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                      OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                                                                                                                                                                      rdfs:label "(PTU SJS)ReportsWithRecveryAsOutcome" ,
                                                                                                                                                                                 "(PTU_SJS) reports with recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)_reports_with_no_recovery_as_outcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)_reports_with_no_recovery_as_outcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                        OpenPVSignal:Reports_group ;
                                                                                                                                                                               OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                               OpenPVSignal:has_count 1 ;
                                                                                                                                                                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                               OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                                                                                                                                                               rdfs:label "(PTU SJS) reports with no recovery as outcome" ,
                                                                                                                                                                                          "(PTU_SJS) reports with no recovery as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)_reports_with_unknown_outcome
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)_reports_with_unknown_outcome> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                 OpenPVSignal:Reports_group ;
                                                                                                                                                                        OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                        OpenPVSignal:has_count 5 ;
                                                                                                                                                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                        OpenPVSignal:refers_to_outcome_after_action "unknown" ;
                                                                                                                                                                        rdfs:label "(PTU SJS) reports with unknown outcome" ,
                                                                                                                                                                                   "(PTU_SJS) reports with unknown outcome" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithConfoundingmedication/co-suspect
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsWithConfoundingmedication/co-suspect> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                               OpenPVSignal:Reports_group ;
                                                                                                                                                                                      OpenPVSignal:has_potential_confounding_factor :carbimazole ,
                                                                                                                                                                                                                                    :cefuroxime ,
                                                                                                                                                                                                                                    :tetracycline ;
                                                                                                                                                                                      OpenPVSignal:is_subgroup_of <http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#(PTU_SJS)ReportsAnalyzed> ;
                                                                                                                                                                                      OpenPVSignal:has_count 3 ;
                                                                                                                                                                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                                                                                      rdfs:label "(PTU SJS)ReportsWithConfoundingmedication/co-suspect" ,
                                                                                                                                                                                                 "(PTU_SJS) reports with confounding medication/co-suspect" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Propylthiouracil_and_Stevens-Johnson_syndrome,_Erythema_multiforme_and_Epidermal_necrolysis
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#Propylthiouracil_and_Stevens-Johnson_syndrome,_Erythema_multiforme_and_Epidermal_necrolysis> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                                                                      OpenPVSignal:Pharmacovigilance_Signal_Report ;
                                                                                                                                                                                                                             OpenPVSignal:refers_to_author :Dr_Zarif_Jabbar-Lopez ;
                                                                                                                                                                                                                             OpenPVSignal:refers_to_signal :pvSignal ;
                                                                                                                                                                                                                             mp:publishedBy :Uppsala_monitoring_centre ;
                                                                                                                                                                                                                             OpenPVSignal:has_creation_date "01/04/2020" ;
                                                                                                                                                                                                                             OpenPVSignal:has_overall_conclusion "Further investigation needed" ;
                                                                                                                                                                                                                             rdfs:label "Propylthiouracil and Stevens-Johnson syndrome, Erythema multiforme and Epidermal necrolysis" .


###  http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#graves'Disease
<http://purl.org/OpenPVSignal/Signals/2013_1_propylthiouracil_Stevens-Johnson_syndrome_erythema_multiforme_epidermal_necrolysis#graves'Disease> rdf:type owl:NamedIndividual ,
                                                                                                                                                         OpenPVSignal:Indication ;
                                                                                                                                                OpenPVSignal:has_ICD_code "E05.00" ;
                                                                                                                                                OpenPVSignal:has_MedDRA_code 10004161 ;
                                                                                                                                                OpenPVSignal:has_MedDRA_prefered_term "Basedow's disease" ;
                                                                                                                                                rdfs:label "graves' disease" .


#################################################################
#    Annotations
#################################################################

:EpidermalNecrolysis rdfs:label "Epidermal necrolysis" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
